
Teva Sees Two Copaxone Scenarios in 2014
– In its 2014 guidance Teva provides a pessimistic scenario with generic Copaxone competition, and an optimistic one with Copaxone exclusivity. – CEO Eyal Desheh, – Teva Pharmaceutical More...
– In its 2014 guidance Teva provides a pessimistic scenario with generic Copaxone competition, and an optimistic one with Copaxone exclusivity. – CEO Eyal Desheh, – Teva Pharmaceutical More...
Wordpress site Developed by Fixing WordPress Problems